Retrospective Study
Copyright ©The Author(s) 2025.
World J Clin Pediatr. Jun 9, 2025; 14(2): 99455
Published online Jun 9, 2025. doi: 10.5409/wjcp.v14.i2.99455
Table 1 Patient demographics and comorbidities for patients with an emergency department visit following ureteroneocystostomy, n (%)/mean ± SD
Patient demographics
Total cohort (n = 1495)
Postoperative ED visit (n = 164)
No Postoperative ED visit (n = 1331)
P value1
Age1666 ±12081605.5 ± 12071673.3 ± 11960.4974
Male gender 446 (29.8)55 (33.5)391 (29.4)0.2720
Non-Caucasian race 304 (20.3)38 (23.2)266 (20.0)0.9070
Hispanic ethnicity201 (13.4)23 (14.0)178 (13.4)0.0109
Inpatient1010 (67.6)120 (73.2)890 (65.9)0.1038
Height40.2 ± 8.939.0 ± 8.340.3 ± 8.60.4041
Weight42.0 (24.3)39.3 (22.5)42.2 (24.5)0.0696
Comorbid conditions/past medical history
Ventilator dependent2 (0.1)1 (0.6)1 (0.1)0.0773
History of asthma25 (1.7)5 (3.0)20 (1.5)0.1453
Bronchopulmonary dysplasia/chronic lung disease14 (0.9)3 (1.8)11 (0.8)0.2085
Oxygen support 10 (0.7)2 (1.2)8 (0.6)0.3594
Tracheostomy2 (0.1)0 (0.0)2 (0.1)0.6195
Structural pulmonary/airway abnormalities 32 (2.1)7 (4.3)25 (1.9)0.0461
Esophageal/gastric/intestinal disease81 (5.4)15 (9.1)66 (5.0)0.0254
History of cardiac surgery30 (2.0)3 (1.8)27 (2.0)0.8637
Developmental delay/impaired cognitive status100 (6.7)15 (9.1)85 (6.4)0.1820
Seizure disorder 17 (1.1)3 (1.8)14 (1.1)0.3758
Cerebral palsy6 (0.4)2 (1.2)4 (0.3)0.0791
Structural CNS abnormality65 (4.3)9 (5.5)56 (4.2)0.4482
Neuromuscular disorder35 (2.3)7 (4.3)28 (2.1)0.0838
Ostomy71 (4.7)13 (7.9)58 (4.4)0.0427
Congenital malformation1144 (76.5)130 (79.3)1014 (76.2)0.6228
Childhood malignancy4 (0.3)0 (0.0)4 (0.3)0.7811
Steroid use (Within 30 days)6 (0.4)2 (1.2)4 (0.3)0.0791
Nutritional support 30 (2.0)5 (3.0)25 (1.9)0.3133
Hematologic disorder33 (2.2)3 (1.8)30 (2.3)0.7270